The impact of membrane lipid composition on macrophage activation in the immune defense against Rhodococcus equi and Pseudomonas aeruginosa

International Journal of Molecular Sciences

Volumn 12, Issue 11, 2011, Pages 7510-7528

  Schoeniger, Axel ^a   Adolph, Stephanie ^a   Fuhrmann, Herbert ^a   Schumann, Julia ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cd86; IL 1 ; IL 10; IL 6; Lysozyme; Macrophage activation; MyD88; PUFA; RAW264.7; TNF

Indexed keywords

ARACHIDONIC ACID; CD86 ANTIGEN; DOCOSAHEXAENOIC ACID; FC RECEPTOR; ICOSAPENTAENOIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; LINOLENIC ACID; LIPOPOLYSACCHARIDE; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE LIPID; MYELOID DIFFERENTIATION FACTOR 88; N (3 OXODODECANOYL)HOMOSERINE LACTONE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN LIKE INTERACTING CASPASE LIKE APOPTOSIS REGULATORY PROTEIN KINASE; RICK PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD86 PROTEIN, MOUSE; FAT INTAKE; MYD88 PROTEIN, MOUSE; UNSATURATED FATTY ACID;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD86 GENE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVITY; FC RECEPTOR GENE; GENE; GENE EXPRESSION; IN VITRO STUDY; INNATE IMMUNITY; LIPID COMPOSITION; LYSOZYME GENE; MACROPHAGE ACTIVATION; MHC CLASS II GENE; MOUSE; MYD88 GENE; NONHUMAN; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; RHODOCOCCUS EQUI; RICK GENE; SIGNAL TRANSDUCTION; UPREGULATION; ACTINOMYCETALES INFECTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CYTOLOGY; FAT INTAKE; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; METABOLISM; PHARMACOLOGY; PSEUDOMONAS INFECTION; RHODOCOCCUS HOAGII;

ACTINOMYCETALES INFECTIONS; ANIMALS; ANTIGENS, CD86; CELL LINE; DIETARY FATS; DOWN-REGULATION; FATTY ACIDS, UNSATURATED; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGE ACTIVATION; MACROPHAGES; MEMBRANE LIPIDS; MICE; MURAMIDASE; MYELOID DIFFERENTIATION FACTOR 88; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RHODOCOCCUS EQUI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 82255164605     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12117510     Document Type: Article

References (36)

1. Stillwell, W.; Wassall, S.R. Docosahexaenoic acid: Membrane properties of a unique fatty acid. Chem. Phys. Lipids 2003, 126, 1-27.
2. Wassall, S.R.; Stillwell, W. Docosahexaenoic acid domains: The ultimate non-raft membrane domain. Chem. Phys. Lipids 2008, 153, 57-63.
3. Chapkin, R.S.; Kim, W.; Lupton, J.R.; McMurray, D.N. Dietary docosahexaenoic and eicosapentaenoic acid: Emerging mediators of inflammation. Prostaglandins Leukot. Essent. Fat. Acids 2009, 81, 187-191.
4. Galli, C.; Calder, P.C. Effects of fat and fatty acid intake on inflammatory and immune responses: A critical review. Ann. Nutr. Metab. 2009, 55, 123-139.
5. Walloschke, B.; Fuhrmann, H.; Schumann, J. Enrichment of RAW264.7 macrophages with essential 18-carbon fatty acids affects both respiratory burst and production of immune modulating cytokines. J. Nutr. Biochem. 2010, 21, 556-560.
6. Schumann, J.; Fuhrmann, H. Impairment of NFkappaB activity by unsaturated fatty acids. Int. Immunopharmacol. 2010, 10, 978-984.
7. Schmutzler, S.; Bachmann, L.; Fuhrmann, H.; Schumann, J. PUFA-dependent alteration of oxidative parameters of a canine mastocytoma cell line. Acta Vet. Hung. 2010, 58, 453-464.
8. Groves, E.; Dart, A.E.; Covarelli, V.; Caron, E. Molecular mechanisms of phagocytic uptake in mammalian cells. Cell. Mol. Life Sci. 2008, 65, 1957-1976.
9. Bryant, C.; Fitzgerald, K.A. Molecular mechanisms involved in inflammasome activation. Trends Cell Biol. 2009, 19, 455-464.
10. Russell, D.G.; Vanderven, B.C.; Glennie, S.; Mwandumba, H.; Heyderman, R.S. The macrophage marches on its phagosome: Dynamic assays of phagosome function. Nat. Rev. Immunol. 2009, 9, 594-600.
11. Hamilton, T.A.; Ohmori, Y.; Tebo, J.M.; Kishore, R. Regulation of macrophage gene expression by pro- and anti-inflammatory cytokines. Pathobiology 1999, 67, 241-244.
12. Trautmann, M.; Lepper, P.M.; Haller, M. Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir of the organism. Am. J. Infect. Control 2005, 33, S41-S49.
13. Prescott, J.F. Rhodococcus equi: An animal and human pathogen. Clin. Microbiol. Rev. 1991, 4, 20-34.
14. Kamboj, M.; Kalra, A.; Kak, V. Rhodococcus equi brain abscess in a patient without HIV. J. Clin. Pathol. 2005, 58, 423-425.
15. Bell, K.S.; Philp, J.C.; Aw, D.W.; Christofi, N. The genus Rhodococcus. J. Appl. Microbiol. 1998, 85, 195-210.
16. Fernandez-Mora, E.; Polidori, M.; Luhrmann, A.; Schaible, U.E.; Haas, A. Maturation of Rhodococcus equi-containing vacuoles is arrested after completion of the early endosome stage. Traffic 2005, 6, 635-653.
17. von, B.K.; Haas, A. Molecular and infection biology of the horse pathogen Rhodococcus equi. FEMS Microbiol. Rev. 2009, 33, 870-891.
18. Blanc, D.S.; Petignat, C.; Janin, B.; Bille, J.; Francioli, P. Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: A prospective epidemiologic study. Clin. Microbiol. Infect. 1998, 4, 242-247.
19. Strateva, T.; Yordanov, D. Pseudomonas aeruginosa-A phenomenon of bacterial resistance. J. Med. Microbiol. 2009, 58, 1133-1148.
20. Pechere, J.C.; Kohler, T. Patterns and modes of beta-lactam resistance in Pseudomonas aeruginosa. Clin. Microbiol. Infect. 1999, 5, S15-S18.
21. Boyen, F.; Eeckhaut, V.; Van, I.F.; Pasmans, F.; Ducatelle, R.; Haesebrouck, F. Quorum sensing in veterinary pathogens: Mechanisms, clinical importance and future perspectives. Vet. Microbiol. 2009, 135, 187-195.
22. Veesenmeyer, J.L.; Hauser, A.R.; Lisboa, T.; Rello, J. Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies. Crit. Care Med. 2009, 37, 1777-1786.
23. Darrah, P.A.; Monaco, M.C.; Jain, S.; Hondalus, M.K.; Golenbock, D.T.; Mosser, D.M. Innate immune responses to Rhodococcus equi. J. Immunol. 2004, 173, 1914-1924.
24. Weldon, S.M.; Mullen, A.C.; Loscher, C.E.; Hurley, L.A.; Roche, H.M. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 acrophages more effectively than eicosapentaenoic acid. J. Nutr. Biochem. 2007, 18, 250-258.
25. Mullen, A.; Loscher, C.E.; Roche, H.M. Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages. J. Nutr. Biochem. 2010, 21, 444-450.
26. Oh, D.Y.; Talukdar, S.; Bae, E.J.; Imamura, T.; Morinaga, H.; Fan, W.; Li, P.; Lu, W.J.; Watkins, S.M.; Olefsky, J.M. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142, 687-698.
27. Mitchell, J.A.; Paul-Clark, M.J.; Clarke, G.W.; McMaster, S.K.; Cartwright, N. Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease. J. Endocrinol. 2007, 193, 323-330.
28. Kumar, H.; Kawai, T.; Akira, S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 2011, 30, 16-34.
29. Park, J.H.; Kim, Y.G.; Nunez, G. RICK promotes inflammation and lethality after Gram-negative bacterial infection in mice stimulated with lipopolysaccharide. Infect. Immun. 2009, 77, 1569-578.
30. Olsson, S.; Sundler, R. The role of lipid rafts in LPS-induced signaling in a macrophage cell line. Mol. Immunol. 2006, 43, 607-612.
31. Wong, S.W.; Kwon, M.J.; Choi, A.M.; Kim, H.P.; Nakahira, K.; Hwang, D.H. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J. Biol. Chem. 2009, 284, 27384-27392.
32. Bishop-Bailey, D.; Bystrom, J. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation. Pharmacol. Ther. 2009, 124, 141-150.
33. Lee, J.Y.; Ye, J.; Gao, Z.; Youn, H.S.; Lee, W.H.; Zhao, L.; Sizemore, N.; Hwang, D.H. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J. Biol. Chem. 2003, 278, 37041-37051.
34. Martinez, J.G.; Waldon, M.; Huang, Q.; Alvarez, S.; Oren, A.; Sandoval, N.; Du, M.; Zhou, F.; Zenz, A.; Lohner, K., et al. Membrane-targeted synergistic activity of docosahexaenoic acid and lysozyme against Pseudomonas aeruginosa. Biochem. J. 2009, 419, 193-200.
35. Helal, R.; Melzig, M.F. New aspects in the synthesis and secretion of lysozyme by cultured human monocyte cell lines. In Vitro Cell. Dev. Biol. Anim. 2010, 46, 492-496.
36. Leaf, D.A.; Connor, W.E.; Barstad, L.; Sexton, G. Incorporation of dietary n-3 fatty acids into the fatty acids of human adipose tissue and plasma lipid classes. Am. J. Clin. Nutr. 1995, 62, 68-73.